The Burrill Report
The Burrill Report (September 26, 2011): What Patent Reforms Means for Biotech (.MP3,13.49 Mb)
The America Invents Act, signed into law earlier this month, has been hailed as the most significant reform of the Patent Act since 1952. Among other things, the new law seeks to better harmonize the U.S. system with other systems around the globe, speed the pace of patent reviews, and cut down on litigation. We spoke to Courtenay Brinckerhoff, partner with Foley & Lardner and editor of the Foley blog PharmaPatentsBlog.com, about the new law, what it means for life sciences companies, and whether it will fix what was broken.
September 22, 2011